Astec LifeSciences Limited (NSE:ASTEC)
India flag India · Delayed Price · Currency is INR
556.30
+2.90 (0.52%)
Nov 17, 2026, 3:30 PM IST

Astec LifeSciences Balance Sheet

Millions INR. Fiscal year is Apr - Mar.

Assets

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Equivalents
14.61100.495.754.724.735.55
Cash & Short-Term Investments
14.61100.495.754.724.735.55
Cash Growth
-84.92%1646.44%22.04%-0.40%-14.63%63.67%
Accounts Receivable
1,0792,4771,4741,6901,5492,736
Other Receivables
-4.873.617.573.9949.78
Receivables
1,1062,5081,5061,7081,5532,788
Inventory
1,7111,3801,5981,9582,9481,869
Prepaid Expenses
-39.1946.8350.0649.7148.67
Other Current Assets
322.02401.75254.94263.67432.41445.57
Total Current Assets
3,1544,4303,4113,9854,9895,157
Property, Plant & Equipment
4,3404,5384,9675,3164,2923,514
Long-Term Investments
0.050.050.050.050.050.05
Other Intangible Assets
236.01247.55234.49194.16159.04113.9
Other Long-Term Assets
214.41204.6201.32254.33354.81183.05
Total Assets
7,9449,4208,8149,7499,7948,968

Liabilities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Accounts Payable
1,082876.65816.13892.781,7721,898
Accrued Expenses
-25.3514.5620.0816.5112.55
Short-Term Debt
-3,0992,6442,8302,8532,394
Current Portion of Long-Term Debt
3,005890.6101.76119.37450.39400
Other Current Liabilities
191.53106.5681109.79170.46201.32
Total Current Liabilities
4,2784,9983,6573,9725,2624,906
Long-Term Debt
3005002,8001,990108.63-
Pension & Post-Retirement Benefits
-4.832.920.513.4910
Long-Term Deferred Tax Liabilities
0.370.370.3867.6209.780.82
Other Long-Term Liabilities
14.748.133.674.424.784.28
Total Liabilities
4,5935,5116,4646,0545,5995,001

Shareholders' Equity

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Common Stock
222.83222.82196.11196.09196.06195.98
Additional Paid-In Capital
-2,950613.92610.9607.36603.48
Retained Earnings
-731.831,5362,8823,3863,162
Comprehensive Income & Other
3,1251.131.273.893.833.07
Total Common Equity
3,3483,9062,3473,6934,1943,965
Minority Interest
3.333.132.712.311.921.63
Shareholders' Equity
3,3513,9092,3503,6954,1963,967
Total Liabilities & Equity
7,9449,4208,8149,7499,7948,968

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Total Debt
3,3054,4895,5454,9393,4122,794
Net Cash (Debt)
-3,290-4,389-5,540-4,934-3,407-2,788
Net Cash Growth
------
Net Cash Per Share
-147.69-204.97-282.47-251.61-173.77-142.26
Filing Date Shares Outstanding
22.2822.2819.6119.6119.6119.6
Total Common Shares Outstanding
22.2822.2819.6119.6119.6119.6
Working Capital
-1,124-567.95-245.7513.33-273.47250.89
Book Value Per Share
150.26175.30119.70188.32213.90202.32
Tangible Book Value
3,1123,6592,1133,4994,0353,851
Tangible Book Value Per Share
139.67164.19107.74178.42205.79196.51
Buildings
-2,0402,0401,7001,2901,286
Machinery
-5,0425,0323,8153,2013,107
Construction In Progress
-1.961.251,4851,124137.32